80 related articles for article (PubMed ID: 11443589)
1. Statins as immunosuppressive agents.
Kobashigawa JA
Liver Transpl; 2001 Jun; 7(6):559-61. PubMed ID: 11443589
[TBL] [Abstract][Full Text] [Related]
2. Statins and cardiac allograft vasculopathy after heart transplantation.
Kobashigawa JA
Semin Vasc Med; 2004 Nov; 4(4):401-6. PubMed ID: 15861321
[TBL] [Abstract][Full Text] [Related]
3. Statins in solid organ transplantation: is there an immunosuppressive effect?
Kobashigawa JA
Am J Transplant; 2004 Jul; 4(7):1013-8. PubMed ID: 15196056
[TBL] [Abstract][Full Text] [Related]
4. Statins as immunomodulatory agents.
Mach F
Circulation; 2004 Jun; 109(21 Suppl 1):II15-7. PubMed ID: 15173058
[TBL] [Abstract][Full Text] [Related]
5. Statins as immunomodulators.
Mach F
Transpl Immunol; 2002 May; 9(2-4):197-200. PubMed ID: 12180830
[TBL] [Abstract][Full Text] [Related]
6. In vivo suppression of major histocompatibility complex class II expression on porcine vascular endothelial cells by an HMG-CoA reductase inhibitor.
Geissler I; Collins L; Schofield R; Fabre JW
Transplantation; 2006 Mar; 81(6):922-6. PubMed ID: 16570018
[TBL] [Abstract][Full Text] [Related]
7. Statins as novel immunomodulators: from cell to potential clinical benefit.
Mach F
Thromb Haemost; 2003 Oct; 90(4):607-10. PubMed ID: 14515180
[TBL] [Abstract][Full Text] [Related]
8. Can the potential benefits of statins in general medical practice be extrapolated to liver transplantation?
Neal DA; Alexander GJ
Liver Transpl; 2001 Dec; 7(12):1009-14. PubMed ID: 11753902
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppressive effects of statins.
Mach F
Atheroscler Suppl; 2002 May; 3(1):17-20. PubMed ID: 12044581
[TBL] [Abstract][Full Text] [Related]
10. Treatment of hyperlipidemia in cardiac transplant recipients.
Bilchick KC; Henrikson CA; Skojec D; Kasper EK; Blumenthal RS
Am Heart J; 2004 Aug; 148(2):200-10. PubMed ID: 15308989
[TBL] [Abstract][Full Text] [Related]
11. Direct anti-inflammatory mechanisms contribute to attenuation of experimental allograft arteriosclerosis by statins.
Shimizu K; Aikawa M; Takayama K; Libby P; Mitchell RN
Circulation; 2003 Oct; 108(17):2113-20. PubMed ID: 14517172
[TBL] [Abstract][Full Text] [Related]
12. Statins induce immunosuppressive effect on heterotopic limb allografts in rat through inhibiting T cell activation and proliferation.
Nie C; Yang D; Liu G; Dong D; Ma Z; Fu H; Zhao Z; Sun Z
Eur J Pharmacol; 2009 Jan; 602(1):168-75. PubMed ID: 19041862
[TBL] [Abstract][Full Text] [Related]
13. Action profiles of statins and calcineurin inhibitors during human mixed lymphocyte reaction.
Takahashi HK; Iwagaki H; Yagi T; Kanke T; Liu K; Yoshino T; Tanaka N; Nishibori M
Clin Immunol; 2007 Jun; 123(3):324-32. PubMed ID: 17482516
[TBL] [Abstract][Full Text] [Related]
14. The inhibitory effects of pravastatin on natural killer cell activity in vivo and on cytotoxic T lymphocyte activity in vitro.
Katznelson S; Wang XM; Chia D; Ozawa M; Zhong HP; Hirata M; Terasaki PI; Kobashigawa JA
J Heart Lung Transplant; 1998 Apr; 17(4):335-40. PubMed ID: 9588577
[TBL] [Abstract][Full Text] [Related]
15. Immunomodulatory effects of HMG-CoA reductase inhibitors.
Danesh FR; Anel RL; Zeng L; Lomasney J; Sahai A; Kanwar YS
Arch Immunol Ther Exp (Warsz); 2003; 51(3):139-48. PubMed ID: 12894868
[TBL] [Abstract][Full Text] [Related]
16. Dual roles of HMG-CoA reductase inhibitors in solid organ transplantation: lipid lowering and immunosuppression.
Katznelson S; Kobashigawa JA
Kidney Int Suppl; 1995 Dec; 52():S112-5. PubMed ID: 8587272
[TBL] [Abstract][Full Text] [Related]
17. HMG-CoA reductase inhibitors in organ transplantation.
Motomura N; Saito S; Foegh ML
J Nephrol; 1997; 10(2):68-76. PubMed ID: 9238613
[TBL] [Abstract][Full Text] [Related]
18. Bidirectional blockade of CD4 and major histocompatibility complex class II molecules: an effective immunosuppressive treatment in the mouse heart transplantation model.
Ito H; Hamano K; Fukumoto T; Wood KJ; Esato K
J Heart Lung Transplant; 1998 May; 17(5):460-9. PubMed ID: 9628564
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacotherapy of arteriosclerosis and its complications. Effect of ACE inhibitors and HMG-CoA-reductase inhibitors].
Tschudi MR; Noll G; Lüscher TP
Schweiz Med Wochenschr; 1997 Apr; 127(15):636-49. PubMed ID: 9198890
[TBL] [Abstract][Full Text] [Related]
20. Immunoglobulin M-to-immunoglobulin G anti-human leukocyte antigen class II antibody switching in cardiac transplant recipients is associated with an increased risk of cellular rejection and coronary artery disease.
Lietz K; John R; Burke E; Schuster M; Rogers TB; Suciu-Foca N; Mancini D; Itescu S
Circulation; 2005 Oct; 112(16):2468-76. PubMed ID: 16230499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
